149 related articles for article (PubMed ID: 22972988)
1. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
[TBL] [Abstract][Full Text] [Related]
2. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
4. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
[TBL] [Abstract][Full Text] [Related]
5. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells.
Bayly R; Chuen L; Currie RA; Hyndman BD; Casselman R; Blobel GA; LeBrun DP
J Biol Chem; 2004 Dec; 279(53):55362-71. PubMed ID: 15507449
[TBL] [Abstract][Full Text] [Related]
6. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
7. Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300.
Denis CM; Langelaan DN; Kirlin AC; Chitayat S; Munro K; Spencer HL; LeBrun DP; Smith SP
Nucleic Acids Res; 2014 Jun; 42(11):7370-82. PubMed ID: 24682819
[TBL] [Abstract][Full Text] [Related]
8. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
Holmlund T; Lindberg MJ; Grander D; Wallberg AE
Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.
Gow CH; Guo C; Wang D; Hu Q; Zhang J
Nucleic Acids Res; 2014 Jan; 42(1):137-52. PubMed ID: 24064250
[TBL] [Abstract][Full Text] [Related]
10. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
Chang CP; de Vivo I; Cleary ML
Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
[TBL] [Abstract][Full Text] [Related]
11. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
[TBL] [Abstract][Full Text] [Related]
12. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
[TBL] [Abstract][Full Text] [Related]
13. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
14. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
[TBL] [Abstract][Full Text] [Related]
15. Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation.
Hyndman BD; Thompson P; Denis CM; Chitayat S; Bayly R; Smith SP; LeBrun DP
Biochim Biophys Acta; 2012 May; 1819(5):375-81. PubMed ID: 22207202
[TBL] [Abstract][Full Text] [Related]
16. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.
Monica K; LeBrun DP; Dedera DA; Brown R; Cleary ML
Mol Cell Biol; 1994 Dec; 14(12):8304-14. PubMed ID: 7969166
[TBL] [Abstract][Full Text] [Related]
17. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
[TBL] [Abstract][Full Text] [Related]
18. E2A basic helix-loop-helix transcription factors in human leukemia.
LeBrun DP
Front Biosci; 2003 May; 8():s206-22. PubMed ID: 12700034
[TBL] [Abstract][Full Text] [Related]
19. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
[TBL] [Abstract][Full Text] [Related]
20. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]